English  |  正體中文  |  简体中文  |  總筆數 :2856565  
造訪人次 :  53375470    線上人數 :  1181
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"kao j h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 731-755 / 1534 (共62頁)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-05-24T07:20:27Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection CHEN-HUA LIU; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:26Z Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:26Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study CHEN-HUA LIU; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:25Z Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction? CHEN-HUA LIU; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:25Z Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C ??authors??reply CHEN-HUA LIU; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:25Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan CHEN-HUA LIU; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:24Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:24Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; CHEN-HUA LIU; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S.
臺大學術典藏 2021-05-24T07:20:24Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:23Z letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors??reply CHEN-HUA LIU; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:23Z Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:23Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:22Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection CHEN-HUA LIU; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:22Z Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium Huang C.-F.; Iio E.; Jun D.W.; Ogawa E.; Toyoda H.; Hsu Y.-C.; Haga H.; Iwane S.; Enomoto M.; Lee D.H.; Wong G.; CHEN-HUA LIU; Tada T.; Chuang W.-L.; Cheung R.; Hayashi J.; Tseng C.-H.; Yasuda S.; Tran S.; Kam L.; Henry L.; Jeong J.Y.; Nomura H.; Park S.H.; Nakamuta M.; Huang J.-F.; Tai C.-M.; Lo G.-H.; Lee M.-H.; Yang H.-I.; Kao J.-H.; Tamori A.; Eguchi Y.; Ueno Y.; Furusyo N.; Tanaka Y.; Yu M.-L.; Nguyen M.H.; For the REAL-C Investigators
臺大學術典藏 2021-05-24T07:20:21Z High Level of Hepatitis B Core?�Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:21Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis CHEN-HUA LIU; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:20Z Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment CHEN-HUA LIU; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:20Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:20Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:19Z Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals CHEN-HUA LIU; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:19Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan CHEN-HUA LIU; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:19Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:19Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:18Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-05-24T07:20:18Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.

顯示項目 731-755 / 1534 (共62頁)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
每頁顯示[10|25|50]項目